document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size font family time roman align center license agreement style margin margin bottom font size font family time roman align center medical device style margin margin bottom text indent font size font family time roman this license agreement this agreement made effective january nbsp effective date between ariad pharmaceutical ariad gene therapeutic both corporation with principal place business landsdowne street cambridge collectively ariad medinol company with principal place business kiryat atidim aviv israel medinol ariad medinol each hereafter referred individually party together party style margin margin bottom text indent font size font family time roman whereas ariad owner otherwise control certain patent technology relating defined below style margin margin bottom text indent font size font family time roman whereas medinol expertise developing commercializing stent which deliver drug product treatment restenosis style margin margin bottom text indent font size font family time roman whereas medinol desire obtain right from ariad evaluate develop commercialize certain medical device including stent that will deliver style margin margin bottom text indent font size font family time roman whereas medinol desire ariad supply quantity medinol research clinical commercial with certain medical device including stent that will deliver style margin margin bottom text indent font size font family time roman whereas ariad desire grant medinol right evaluate develop commercialize certain medical device including stent that will deliver supply quantity medinol connection therewith term condition forth this agreement supply agreement defined below style margin margin bottom text indent font size font family time roman therefore consideration mutual covenant contained herein other good valuable consideration receipt adequacy which hereby acknowledged party hereby agree follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign definition table style margin margin bottom text indent font size font family time roman whenever used agreement with initial capital letter term defined this article shall have meaning specified style margin margin bottom text indent font size font family time roman adverse event shall mean untoward medical occurrence required reported regulatory authority including without limitation style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman occurrence defined serious adverse event applicable regulatory authority regulation guideline including european standard patient been administered style margin margin bottom text indent font size font family time roman affiliate shall mean corporation firm limited liability company partnership other entity that directly control controlled under common control with party this agreement purpose this section nbsp control mean ownership directly indirectly through more entity fifty percent nbsp more share stock entitled vote election director case corporation fifty percent nbsp more equity interest case other type legal entity status general partner partnership other arrangement whereby party control right control board director equivalent governing body corporation other entity style margin margin bottom text indent font size font family time roman shall mean active pharmaceutical ingredient style margin margin bottom text indent font size font family time roman shall mean ariad proprietary compound designated described filed ariad with style margin margin bottom text indent font size font family time roman phase clinical data shall mean narrative summary report prepared ariad unaudited clinical data obtained ariad patient enrolled phase clinical trial date which three week preceding date each such summary report each such narrative summary report shall summarize each protocol number enrolled patient receiving each dosage level accordance with each protocol safety information which shall comprise adverse event reported draft data listing serious adverse event required reported regulatory authority obtained ariad purpose clarity phase clinical data nbsp subject change after audit nbsp shall treated confidential information ariad nbsp shall used medinol solely internal purpose performing obligation exercising right under this agreement supply agreement nbsp shall disclosed medinol third party under circumstance without ariad prior written consent style margin margin bottom text indent font size font family time roman phase clinical trial shall mean only following study nbsp conducted accordance with protocol nbsp conducted accordance with protocol style margin margin bottom text indent font size font family time roman authorized distributor shall mean seller distributor medinol licensed product approved ariad pursuant section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman mark shall mean conformite europeene mark issued upon approval european union regulatory authority market sell medinol licensed product country european union style margin margin bottom text indent font size font family time roman change control shall have meaning forth section style margin margin bottom text indent font size font family time roman data mean chemistry manufacturing control data forth same amended from time time otherwise required applicable regulation included equivalent application regulatory authority grant marketing authorization outside united state such data amended supplemented from time time purpose clarity data shall treated confidential information purpose this agreement style margin margin bottom text indent font size font family time roman confidential information shall mean nbsp with respect party receiving party information including without limitation with respect ariad data from phase clinical trial chemical structure with respect each party licensed technology data development plan schedule marketing sale information clinical clinical data information result specification protocol which disclosed other party disclosing party receiving party hereunder employee consultant affiliate which designated confidential information prior during immediately after such disclosure confidential information include information which nbsp date disclosure known receiving party affiliate demonstrated written record other than virtue prior confidential disclosure such party affiliate nbsp date disclosure subsequently enters public domain through breach this agreement receiving party nbsp obtained from third party having lawful right make such disclosure free from obligation confidentiality disclosing party nbsp independently developed receiving party without reference reliance upon confidential information disclosing party demonstrated written record style margin margin bottom text indent font size font family time roman control controlled shall mean with respect patent right technology possession party ability grant license sublicense such patent right technology provided herein without violating term agreement between such party third party without requiring such party make contractual payment third party connection with such grant right exercise thereof grantee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman current good laboratory practice cglp shall mean current good laboratory practice standard described directive european parliament council nbsp february directive european parliament council nbsp february part amended from time time style margin margin bottom text indent font size font family time roman current good manufacturing practice cgmp shall mean european community requirement good manufacturing practice forth commission directive amended guidance document issued pursuant them forth title united state code federal regulation part amended from time time style margin margin bottom text indent font size font family time roman drug master file shall mean drug master file amendment supplement thereto filed maintained with regulatory authority behalf ariad which shall contain among other thing data other relevant information concerning style margin margin bottom text indent font size font family time roman excess cost defined supply agreement mean difference between nbsp purchase price gram following expiration notice period refusal supply ariad minus nbsp amount equal dollar subject annual adjustment inflation from effective date date purchase medinol using united state bureau labor statistic producer price index pharmaceutical preparation manufacturing published calculate excess cost payment made medinol foreign currency shall converted into united state dollar conversion rate existing united state reported wall street journal eastern edition purchasing united state dollar last business applicable calendar quarter which purchase took place style margin margin bottom text indent font size font family time roman exclusive licensee shall mean medinol nbsp additional third party granted license under ariad interest licensed patent right licensed technology develop have developed make have made have used sell have sold offer sale import have imported export have exported distribute market promote licensed product licensed field style margin margin bottom text indent font size font family time roman shall mean united state food drug administration successor agency authority thereto style margin margin bottom text indent font size font family time roman first commercial sale shall mean country country basis date first length transaction transfer disposition value style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman third party medinol licensed product behalf medinol affiliate medinol such country specifically excluding transfer made furtherance clinical trial research other such commercial style margin margin bottom text indent font size font family time roman first human clinical trial shall mean with respect medinol licensed product first study human medinol licensed product investigational device accordance with applicable rule regulation country jurisdiction which clinical trial conducted style margin margin bottom text indent font size font family time roman shall mean investigational device exemption defined title united state code federal regulation part amended from time time filed file with style margin margin bottom text indent font size font family time roman shall mean investigational drug application defined title united state code federal regulation part amended from time time filed filed with style margin margin bottom text indent font size font family time roman licensed field shall mean style margin margin bottom text indent font size font family time roman licensed patent right shall mean patent right that nbsp controlled ariad effective date extent necessary develop make have made import have imported export have exported sell have sold offer sell distribute market promote medinol licensed product licensed field nbsp become controlled ariad during license term extent necessary medinol develop make have made import have imported export have exported sell have sold offer sell distribute market promote medinol licensed product licensed field licensed patent right effective date listed schedule attached hereto made part hereof during term ariad shall provide medinol annual written update schedule which includes additional patent patent application comprising licensed patent previously listed style margin margin bottom text indent font size font family time roman licensed product shall mean medical device which delivers style margin margin bottom text indent font size font family time roman licensed technology shall mean include technology whether patentable including limited formulation technique material that nbsp controlled ariad effective date extent necessary medinol develop make have made import have imported export have exported sell have sold offer sell distribute market promote medinol licensed product licensed field nbsp becomes controlled ariad during license term extent necessary medinol make have made medinol licensed product licensed field style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman license term shall mean with respect each medinol licensed product period commencing effective date continuing country country product product basis until expiration termination last valid claim covering manufacture sale importation such country style margin margin bottom text indent font size font family time roman medical device shall mean style margin margin bottom text indent font size font family time roman medinol gore agreement shall mean collaboration agreement between medinol gore dated september nbsp style margin margin bottom text indent font size font family time roman medinol licensed product shall mean embodiment licensed product manufactured exclusively medinol sold medinol gore medinol authorized distributor which patent right reasonably believed medinol owned controlled medinol which medinol reasonably belief otherwise right practice patent right avoidance doubt medinol licensed product shall include embodiment licensed product manufactured exclusively medinol which bundled sale medinol gore medinol authorized distributor with other product product each which medinol licensed product example medinol licensed product sold gore either single unit bundled with other product manufactured exclusively gore pursuant medinol gore agreement style margin margin bottom text indent font size font family time roman shall mean drug application filed with equivalent successor application entity seeking authorization market style margin margin bottom text indent font size font family time roman sale shall mean gross invoiced sale price medinol licensed product sold medinol gore medinol authorized distributor their respective affiliate subdistributors gore medinol authorized distributor third party throughout world during each calendar quarter before deduction promotional discount promotion royalty duty charge other expense such seller before reimbursement made customer after deduction other discount individual customer excess medinol licensed product customer style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman patent right shall mean right interest issued patent pending patent application including inventor certificate utility model country jurisdiction including provisionals substitution continuation continuation part divisionals supplementary protection certificate renewal letter patent granted thereon reissue reexamination extension confirmation revalidations registration patent addition thereof foreign counterpart style margin margin bottom text indent font size font family time roman patented medinol licensed product shall mean medinol licensed product manufactured sold country which there valid claim licensed patent right time manufacture sale style margin margin bottom text indent font size font family time roman permitted assignee shall mean assignee assuming right obligation party under this agreement pursuant change control style margin margin bottom text indent font size font family time roman pivotal clinical trial shall mean with respect medinol licensed product well controlled study human designed determine taking into account statistical consideration safety efficacy such medinol licensed product which designed demonstrate whether such medinol licensed product safe effective more indication licensed field style margin margin bottom text indent font size font family time roman shall mean application obtain market approval defined title united state code federal regulation part amended from time time filed with style margin margin bottom text indent font size font family time roman registration process shall mean ariad manufacturing process manufacturing under cgmp which validated reproducible achieve regulatory approval medinol licensed product united state european union style margin margin bottom text indent font size font family time roman regulatory approval shall mean approval applicable regulatory authority necessary market sell medinol licensed product country jurisdiction style margin margin bottom text indent font size font family time roman regulatory authority shall mean applicable supranational national federal state local regulatory agency department bureau other governmental entity country jurisdiction including united state having responsibility such country jurisdiction regulatory approval kind such country jurisdiction successor agency authority thereto style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman stent shall mean metal wire mesh tube that placed mean catheter site blockage within artery keep vessel open after balloon angioplasty style margin margin bottom text indent font size font family time roman supply agreement shall mean that certain supply agreement entered into even date herewith between ariad medinol form attached hereto exhibit style margin margin bottom text indent font size font family time roman technology shall mean include unpatented proprietary idea invention discovery confidential information biological material data result formula design specification method process formulation technique idea know technical information including without limitation structural functional information process information clinical information clinical information proprietary biological chemical pharmacological toxicological clinical clinical assay control manufacturing data material case medinol mechanical mechanical design material science data material style margin margin bottom text indent font size font family time roman term shall mean have meaning forth section style margin margin bottom text indent font size font family time roman third party shall mean person entity other than medinol ariad style margin margin bottom text indent font size font family time roman unpatented medinol licensed product shall mean medinol licensed product that neither manufactured sold country which there valid claim licensed patent right time manufacture sale style margin margin bottom text indent font size font family time roman valid claim shall mean claim issued unexpired patent within licensed patent right that nbsp been finally cancelled withdrawn abandoned rejected administrative agency other body competent jurisdiction nbsp been revoked held invalid declared unpatentable unenforceable decision court other body competent jurisdiction that unappealable unappealed within time allowed appeal nbsp been rendered unenforceable through disclaimer otherwise nbsp lost through interference proceeding style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman gore shall mean gore associate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign grant right table style margin margin bottom text indent font size font family time roman license retained right style margin margin bottom text indent font size font family time roman grant license subject term condition this agreement ariad hereby grant medinol exclusive with other exclusive licensee worldwide royalty bearing license during term with right grant sublicenses solely medinol affiliate gore medinol authorized distributor other seller distributor medinol product affiliate gore authorized distributor purchase medinol product from gore authorized distributor including multi tiered distribution channel solely enable such affiliate gore authorized distributor other such seller distributor market sell medinol licensed product under ariad interest licensed patent right licensed technology develop have developed make have made have used sell have sold offer sell import have imported export have exported distribute market promote medinol licensed product licensed field style margin margin bottom text indent font size font family time roman retained right subject other term this agreement ariad retains right licensed technology licensed patent right including without limitation right style margin margin bottom text indent font size font family time roman develop have developed make have made have used sell have sold offer sale import have imported export have exported distribute market promote product except that ariad shall have right have used sell have sold offer sale import have imported export have exported distribute market promote licensed product licensed field style margin margin bottom text indent font size font family time roman grant license affiliate third party under ariad interest licensed patent right licensed technology except that ariad will grant more than nbsp exclusive license exclusive licensee under ariad interest licensed patent right licensed technology develop have developed make have made have used sell have sold offer sale import have imported export have exported distribute market promote licensed product licensed field style margin margin bottom text indent font size font family time roman make have made sell supply purpose provided that ariad will licensed product licensed field supply party licensed product licensed field other than medinol hereunder under supply agreement exclusive licensee licensed accordance with clause nbsp above style margin margin bottom text indent font size font family time roman otherwise develop exploit licensed patent right licensed technology purpose other than licensed product licensed field style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman right license granted hereunder implication estoppel otherwise except expressly forth herein restriction limitation ariad retained right clause nbsp nbsp this section nbsp shall country country basis terminate become void upon expiration termination licensed term each such country style margin margin bottom text indent font size font family time roman authorized distributor medinol wish appoint seller distributor medinol licensed product other then gore shall notify ariad shall provide ariad with material information regarding relationship copy relevant agreement collectively distributor information third party shall appointed seller distributor medinol licensed product without written approval ariad which shall unreasonably withheld ariad shall respond request approval within nbsp receipt distributor information from medinol ariad approval proposed seller distributor withheld ariad shall notify medinol writing within such period including explanation reason therefor some example complete list reason ariad withhold approval proposed seller distributor include ariad reasonable belief that such proposed seller distributor history under performance competitive with ariad affiliate adverse ariad affiliate pending threatened dispute would cause ariad affiliate breach under conflict with agreement decree rule regulation governing ariad business medinol shall remain obligated performance under this agreement notwithstanding medinol sublicense appointment gore authorized distributor sell distribute medinol license product medinol behalf style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign development commercialization product table style margin margin bottom text indent font size font family time roman development obligation ariad medinol obligation concerning development commercialization medinol licensed product forth this article style margin margin bottom text indent font size font family time roman ariad obligation during term ariad sole expense ariad shall commercially reasonable effort style margin margin bottom text indent font size font family time roman long ariad pharmaceutical partner continue development treat cancer take action necessary continue development manufacture under cgmp order facilitate medinol effort pursuant section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman mutually agreed provide medinol from time time such phase clinical data facilitate medinol meeting obligation pursuant section nbsp medinol shall maintain such phase clinical data confidence shall disclose third party except expressly permitted under section nbsp this agreement style margin margin bottom text indent font size font family time roman soon practicable following completion phase clinical trial provide medinol final audited report clinical data including adverse event obtained from patient enrolled ariad phase nbsp clinical trial medinol shall maintain final audited report disclosed pursuant this section nbsp confidence shall disclose third party except expressly permitted under section nbsp this agreement style margin margin bottom text indent font size font family time roman take action necessary file maintain with respect made using registration process timetable mutually agreed between ariad medinol style margin margin bottom text indent font size font family time roman take action necessary including completion ongoing phase clinical trial file maintain european with respect made using registration process timetable mutually agreed between ariad medinol style margin margin bottom text indent font size font family time roman take action agreed upon party necessary seek marketing approval japan timetable mutually agreed between ariad medinol style margin margin bottom font size font family time roman purpose clarity acknowledged that nbsp ariad obligation under this section nbsp shall limited drug independent medical device shall apply medinol licensed product nbsp ariad obligation under this section nbsp commercially reasonable effort require ariad pharmaceutical partner continue development manufacture regulatory approval effort with respect ariad pharmaceutical partner reasonable commercial judgment their business interest style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman medinol obligation during term medinol sole expense medinol shall commercially reasonable effort style margin margin bottom text indent font size font family time roman take action necessary develop manufacture medinol licensed product under cgmp market itself through affiliate gore authorized distributor such medinol licensed product united state european union japan order achieve milestone cause ariad receive payment forth section nbsp soon practicable style margin margin bottom text indent font size font family time roman initiate first clinical trial using medinol licensed product timetable mutually agreed between ariad medinol style margin margin bottom text indent font size font family time roman take action necessary including conduct necessary clinical trial file medinol licensed product timetable mutually agreed between ariad medinol style margin margin bottom text indent font size font family time roman take action necessary including conduct necessary clinical trial file mark medinol licensed product europe timetable mutually agreed between ariad medinol style margin margin bottom text indent font size font family time roman take action necessary including conduct necessary clinical trial seek pricing marketing approval medinol licensed product japan timetable mutually agreed between ariad medinol style margin margin bottom font size font family time roman medinol obligation under this section nbsp require medinol continue development manufacture clinical development regulatory work with respect medinol licensed product medinol reasonable commercial judgment medinol business interest style margin margin bottom text indent font size font family time roman compliance with regulation undertaking respective obligation pursuant this article nbsp each ariad medinol shall comply with applicable regulation ordinance guideline without limiting generality foregoing with respect conduct clinical trial human sponsored party such party agent representative shall ensure compliance with among other thing applicable standard good clinical practice ichgcp guideline other regulation other regulatory authority governing performance such clinical investigation style margin margin bottom text indent font size font family time roman supply agreement contemporaneously with execution hereof ariad medinol shall enter into supply agreement pursuant which ariad shall supply medinol shall purchase term condition forth exhibit attached hereto style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman project committee reporting style margin margin bottom text indent font size font family time roman project committee each party shall designate appropriate individual serve principal liaison principal liaison party principal liaison shall serve principal point contact other party shall coordinate manage performance that party obligation under this agreement principal liaison shall function project committee shall meet person telephone minimum quarterly basis purpose project committee operation party understand acknowledge that ariad employee have contribute expertise area pharmaceutical product development testing commercialization medinol employee have contribute expertise area medical device product development testing commercialization style margin margin bottom text indent font size font family time roman committee operation project committee shall establish procedure regular quarterly meeting which shall nbsp provide summary progress report discus cooperate resolve technical regulatory issue relating development commercialization medinol licensed product encountered either party nbsp discus help development strategy commercialize medinol licensed product worldwide nbsp provide input development plan each medinol licensed product including without limitation assistance with development timeline achievement each party obligation specified section order seek marketing approval medinol licensed product united state european union japan nbsp discus implement procedure coordinate manage each party activity meeting respective obligation section addition participation such quarterly meeting ariad shall reasonable effort provide technical regulatory assistance medinol within area expertise solely related assist medinol develop manufacture obtain regulatory approval market medinol licensed product such assistance shall organized through principal liaison ariad medinol shall principal contact project manager development medinol licensed product their respective company information shared project committee meeting shall treated confidential information disclosing party recipient shall such information only purpose expressly permitted under this agreement sake clarity stressed that information exchanged under mutual program pursuant this agreement will shared ariad with other exclusive licensee without written consent medinol style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman regulatory information during term party shall share information clinical regulatory purpose follows style margin margin bottom text indent font size font family time roman investigator safety letter each party shall promptly event later than hour before expiration earliest deadline provide notice clinical investigator pursuant relevant guideline regulatory authority governing conduct clinical trial worldwide provide copy investigator safety letter generated affiliate licensee connection with worldwide clinical study product containing principal liaison other party upon receipt thereof party receiving such investigator safety letter shall nbsp timely accordance with relevant guideline regulatory authority disseminate cause disseminated such investigator safety letter each clinical investigator conducting clinical trial patient population worldwide with product containing behalf affiliate licensee nbsp within hour thereafter confirm writing principal liaison party disclosing such investigator safety letter that complied with obligation clause nbsp this sentence style margin margin bottom text indent font size font family time roman medinol data subject applicable governing patient confidentiality extent necessary ariad comply with applicable statute regulation ordinance guideline governing regulatory approval medinol shall provide ariad nbsp electronic database format safety data including adverse event from worldwide clinical trial relating medinol licensed product nbsp copy investigator safety letter provided medinol clinical investigator connection with clinical study medinol licensed product nbsp only extent reasonably necessary ariad obtain regulatory approval summary relevant data generated medinol connection with preclinical study product containing collectively medinol data medinol data shall treated confidential information ariad shall maintain such medinol data disclosed pursuant this section nbsp confidence shall disclose third party other than disclose itself through agent such medinol data after obtaining assurance that such medinol data will afforded confidential treatment recipient exclusive licensee pharmaceutical partner regulatory authority solely required order such recipient obtain grant case regulatory approval product containing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman ariad data subject applicable governing patient confidentiality extent necessary medinol comply with applicable statute regulation ordinance guideline governing regulatory approval medinol licensed product ariad shall provide medinol nbsp right cross reference safety data including adverse event reported ariad under obtain regulatory approval nbsp copy investigator safety letter provided ariad clinical investigator connection with clinical study nbsp only extent reasonably necessary medinol obtain regulatory approval medinol licensed product summary relevant data generated ariad connection with preclinical study nbsp summary report safety data including adverse event attributable provided ariad party granted license pursuant ariad retained right section nbsp together with ariad audited report referred section nbsp ariad data ariad data shall treated confidential information medinol shall maintain such ariad data disclosed pursuant this section nbsp confidence shall disclose third party other than nbsp medinol itself through agent provide cross reference ariad data reported ariad under corresponding foreign country filing obtain regulatory approval country disclose ariad data written submission such regulatory authority each case solely required obtain regulatory approval medinol licensed product licensed field only after obtaining prior written permission from ariad make such disclosure which conditioned upon medinol obtaining written assurance from regulatory authority whom information being disclosed that such ariad data will afforded confidential treatment such regulatory authority nbsp medinol upon prior notice ariad verbally disclose ariad data teleconference meeting with regulatory authority each case solely required obtain regulatory approval medinol licensed product licensed field only after obtaining prior written permission from ariad which conditioned upon affording appropriate ariad personnel opportunity participate each such teleconference meeting style margin margin bottom text indent font size font family time roman medinol licensed product report during term addition requirement forth section nbsp medinol shall provide project committee with written report that summarize medinol effort develop commercialize medinol licensed product hereunder addition medinol shall provide project committee with prompt written notice occurrence first commercial sale medinol licensed product each country which medinol licensed product introduced ariad acknowledges that report provided medinol pursuant this section nbsp medinol confidential information shall such information only purpose expressly permitted under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman ariad development program report during term ariad shall provide project committee with written report that summarize ariad effort obtain regulatory approval territory progress arranging supply medinol with timely basis according this agreement supply agreement other word ariad progress with manufacturing development program medinol acknowledges that report provided ariad pursuant this section nbsp ariad confidential information shall such information only purpose expressly permitted under this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign payment royalty table style margin margin bottom text indent font size font family time roman license partial consideration this agreement medinol hereby agrees ariad effective date refundable creditable upfront amount seven hundred fifty thousand dollar style margin margin bottom text indent font size font family time roman intentionally omitted style margin margin bottom text indent font size font family time roman payment royalty royalty rate further consideration grant license granted under section nbsp subject other term this agreement including remainder this section nbsp commencing date first commercial sale each medinol licensed product each country medinol shall ariad royalty sale medinol licensed product follows royalty rate shall nbsp with respect medinol licensed product nbsp percent sale unit such medinol licensed product sold each calendar year nbsp percent sale such medinol licensed product sold each calendar year nbsp with respect medinol licensed product nbsp percent sale first unit such medinol licensed product sold each calendar year nbsp percent sale such medinol licensed product sold each calendar year event that calendar quarter medinol actually make payment excess cost purchase from third party approved manufacturer make have medinol licensed product then medinol shall have right reduce royalty otherwise ariad pursuant this section nbsp only over next consecutive quarter following calendar quarter which such payment excess cost made medinol percent such excess cost notwithstanding foregoing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman reduction payment excess cost pursuant this section nbsp shall event reduce royalty ariad calendar quarter than percent sale medinol licensed product royalty payment shall payable nbsp patented medinol licensed product until expiration termination last valid claim within licensed patent right both country where medinol licensed product manufactured country where medinol licensed product sold nbsp unpatented medinol licensed product until year from date first commercial sale unpatented medinol licensed product each country determined country country medinol licensed product medinol licensed product basis avoidance doubt clause nbsp shall applicable patented medinol licensed product which become unpatented medinol licensed product result expiration patent remainder year period style margin margin bottom text indent font size font family time roman milestone payment style margin margin bottom text indent font size font family time roman payment further consideration license granted under section nbsp subject other term condition this agreement medinol shall make refundable creditable payment forth table below ariad within thirty nbsp first achievement each following event medinol affiliate partner with respect nbsp medinol licensed product nbsp each medinol licensed product purpose clarity expressly agreed that these milestone payment will payable only once medinol licensed product when first medinol licensed product reach each milestone medinol licensed product which will trigger separate milestone payment hereunder mean another style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom font size font family time roman milestone style margin margin bottom border bottom solid width font size font family time roman number valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center milestone valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid milestone payment valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom style margin left text indent font size font family time roman initiation valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom style margin left text indent font size font family time roman initiation valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom style margin left text indent font size font family time roman submission medinol licensed product valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom style margin left text indent font size font family time roman completion valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom style margin left text indent font size font family time roman granting valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom style margin left text indent font size font family time roman filing valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom style margin left text indent font size font family time roman granting valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom style margin left text indent font size font family time roman granting valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp valign bottom style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman determination that payment medinol shall provide ariad with prompt written notice upon achievement each milestone forth section nbsp event that ariad belief milestone payment spite having received notice from medinol shall notify medinol shall provide medinol data information reasonably supporting belief that condition payment have been achieved medinol provide reasonable evidence that such milestone been achieved within forty five nbsp receipt data information from ariad condition such milestone payment under section nbsp shall deemed have been achieved style margin margin bottom text indent font size font family time roman payment term style margin margin bottom text indent font size font family time roman payment royalty milestone except otherwise provided herein medinol shall make milestone license royalty payment owed ariad hereunder arrears within sixty nbsp following each calendar quarter which such payment accrues purpose determining when sale medinol licensed product occurs under this agreement royalty shall accrue date payment invoice purchaser medinol licensed product each royalty payment shall accompanied report each country which sale medinol licensed product occurred which royalty payment calendar quarter covered such statement specifying nbsp gross sale available sale each country currency nbsp applicable royalty rate under this agreement nbsp royalty payable dollar including accounting deduction taken calculation sale nbsp applicable exchange rate used convert from each country currency united state dollar under this section nbsp event shall more than royalty ariad unit medinol licensed product sold medinol affiliate gore authorized distributor other seller distributor medinol licensed product hereunder style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman overdue royalty subject other term this agreement royalty paid within time period forth this article shall bear interest rate lesser either maximum legally allowable interest rate percent month from date until paid full style margin margin bottom text indent font size font family time roman accounting payment hereunder shall made united state united state dollar conversion foreign currency dollar shall made conversion rate existing united state reported wall street journal eastern edition purchasing united state dollar last business applicable calendar quarter which sale took place wall street journal cease published then rate exchange used shall that reported such other business publication national circulation united state party reasonably agree each party shall deduct which party obligated withhold country payment under this agreement them proper authority required applicable therefore agreed understood that amount paid under term this agreement such calculation royalty according section nbsp milestone payment according section nbsp calculated gross payment each party shall maintain official receipt payment such forward these receipt other party within sixty nbsp such payment shall provide reasonable assistance other party obtaining legally credit refund such style margin margin bottom text indent font size font family time roman withholding restriction payment payment hereunder shall made free clear duty levy charge except withholding forth section nbsp regulation fiscal policy particular country remittance royalty united state dollar restricted forbidden written notice thereof shall promptly given ariad payment royalty shall made deposit thereof local currency credit ariad recognized banking institution reasonably designated ariad written notice medinol when country regulation prohibit both transmittal deposit royalty sale such country royalty payment shall made dollar from united state long such prohibition effect style margin margin bottom text indent font size font family time roman record retention review style margin margin bottom text indent font size font family time roman royalty record retention commencing date first commercial sale first medinol licensed product medinol gore authorized distributor their affiliate shall retain minimum three nbsp year from calendar year which they pertain complete accurate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman record sale medinol gore authorized distributor their affiliate case each medinol licensed product sufficient detail allow accuracy payment hereunder confirmed style margin margin bottom text indent font size font family time roman review royalty record subject other term this section nbsp upon thirty nbsp prior written request from ariad more frequently than once each calendar year ariad expense except provided this section nbsp below medinol shall permit independent certified public accountant reasonably selected ariad reasonably acceptable medinol inspect during regular business hour relevant record required maintained medinol under this section nbsp every case accountant must have previously entered into confidentiality agreement with both party substantially similar provision section nbsp limiting disclosure such information such accountant authorized representative party purpose germane this section nbsp result such review shall binding both party absent manifest error each party agrees treat result such accountant review other party record under this section nbsp confidential information other party subject term section nbsp review reveals deficiency calculation royalty resulting from underpayment medinol medinol shall promptly ariad amount remaining paid such underpayment percent more medinol shall reasonable pocket cost expense review style margin margin bottom text indent font size font family time roman affiliate distributor medinol shall cause gore authorized distributor medinol licensed product their affiliate retain record relating medinol licensed product permit ariad inspect such record same manner forth this section style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign treatment confidential information table style margin margin bottom text indent font size font family time roman confidential obligation style margin margin bottom text indent font size font family time roman each party shall deemed owner right title interest including intellectual property right confidential information that party ariad medinol each agree that during term thereafter shall nbsp keep confidential shall cause officer employee consultant third party contractor licensee officer employee consultant third party contractor licensee affiliate keep confidential confidential information other party nbsp shall cause officer employee consultant third party contractor licensee officer employee consultant third party contractor licensee affiliate confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman information other party solely purpose expressly permitted under this agreement each party shall take such action shall cause affiliate take such action preserve confidentiality each other confidential information would customarily take preserve confidentiality confidential information than reasonable action style margin margin bottom text indent font size font family time roman ariad medinol each agree that disclosure other party confidential information officer employee consultant third party contractor licensee other party affiliate gore authorized distributor case medinol shall made only extent necessary perform obligation exercise right under this agreement shall limited maximum extent possible consistent with such obligation right shall only made person bound written confidentiality obligation maintain confidentiality thereof such confidential information except expressly permitted this agreement medinol shall maintain confidential information ariad comprising structure data other chemistry data secure file with access limited medinol regulatory personnel shall maintain tracking personnel access such data without limiting generality foregoing medinol shall cause gore each authorized distributor execute written confidentiality agreement with ariad form substance satisfactory ariad medinol hereby guarantee full complete compliance gore each authorized distributor with term such confidentiality agreement shall liable breach thereof gore authorized distributor person entity receiving confidential information ariad directly indirectly from gore style margin margin bottom text indent font size font family time roman notwithstanding provision section nbsp ariad medinol agree disclose transfer other party confidential information third party under circumstance without prior written approval from other party such approval unreasonably withheld except nbsp filing prosecuting patent application maintaining patent which filed accordance with article this agreement except that medinol disclose chemical structure descriptive information sufficient determine chemical structure connection therewith without ariad prior written consent nbsp filing prosecuting defending litigation accordance with provision article except that medinol voluntarily disclose chemical structure descriptive information sufficient determine chemical structure connection therewith without ariad prior written consent nbsp required obtain regulatory approval market sell medinol licensed product nbsp reasonably necessary obtain service third party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman contractor connection with preclinical clinical development medinol licensed product except that medinol disclose chemical structure without ariad prior written consent nbsp permitted supply agreement nbsp complying with court order provided however that party required make such disclosure other party confidential information pursuant court order discovery request will give reasonable advance notice other party such disclosure requirement will reasonable effort assist such other party effort limit disclosure such information maximum extent possible secure confidential treatment such information required disclosed style margin margin bottom text indent font size font family time roman each party upon request other party will return destroy confidential information disclosed transferred other party pursuant this agreement including copy extract document manifestation whatever form upon termination expiration this agreement provided however that nbsp copy such confidential information retained secure location solely purpose establishing compliance with this agreement required regulation style margin margin bottom text indent font size font family time roman party acknowledge agree that breach threatened breach article will result irreparable harm party whose confidential information subject such breach threatened breach which remedy will adequate each party disclosing party shall therefore entitled seek injunctive relief court competent jurisdiction addition other remedy equity event breach threatened breach this article style margin margin bottom text indent font size font family time roman publication notwithstanding confidentiality obligation forth this section nbsp medinol affiliate academic collaborator shall have right publish solely recognized peer reviewed scientific journal present result clinical study order balance this right with ariad proprietary interest medinol will submit ariad review manuscript other material intended publication abstract poster other disclosure proposed disclosure least thirty nbsp prior date submission publication other disclosure ariad will complete review within thirty nbsp receipt proposed disclosure prior such publication other disclosure ariad shall have right review request that medinol delete reference ariad confidential information excluding result medinol clinical study delayed pursuant preceding sentence period medinol will have right publish present disclosure amended ariad style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman publicity neither party publicly disclose existence term other matter fact regarding this agreement without prior written consent other party which consent shall unreasonably withheld delayed provided however that either party make such disclosure nbsp extent required requirement nationally recognized security exchange quotation system over counter market which such party security listed traded intends listed traded nbsp professional advisor potential acquirer investor prospective investor lender other potential financing source obligated keep such information confidential event that such disclosure required aforesaid clause disclosing party shall make reasonable effort provide other party with notice beforehand coordinate with other party with respect wording timing such disclosure party shall mutually agree form timing press release with respect this transaction once such press release other written statement approved disclosure both party either party make subsequent public disclosure content such statement without further approval other party style margin margin bottom text indent font size font family time roman name neither party shall employ name other party promotional material advertising without prior express written permission other party style margin margin bottom text indent font size font family time roman trademark medinol shall have right market medinol licensed product under trademark selected medinol commercial medinol licensed product must reflect ariad then current product mark description style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign provision concerning filing prosecution maintenance patent right ownership invention table style margin margin bottom text indent font size font family time roman patent filing prosecution maintenance subject other term this section nbsp ariad shall responsible preparing filing prosecuting obtaining maintaining sole cost expense discretion acting through patent attorney agent choice licensed patent right each country listed exhibit medinol represents that country listed exhibit comprise market wherein medinol intends market sell medinol licensed product effective date ariad nbsp will provide medinol with copy pending claim licensed patent right that relevant licensed field nbsp will keep medinol reasonably informed issuance abandonment such claim style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman notice infringement during license term either party learns actual alleged threatened infringement third party licensed patent right licensed field under this agreement such party shall promptly notify other party shall extent lawfully provide such other party with available evidence such infringement style margin margin bottom text indent font size font family time roman infringement patent right ariad shall have right obligation expense with legal counsel choice bring suit take other appropriate legal action against actual alleged threatened infringement licensed patent right licensed field medinol shall have right expense represented such action counsel medinol choice provided however that under circumstance shall foregoing affect right ariad control suit described first sentence this section nbsp ariad brings such action proceeding hereunder nbsp medinol agrees joined party plaintiff necessary prosecute such action proceeding nbsp ariad expense medinol shall give ariad reasonable assistance authority file prosecute suit nbsp ariad shall permitted settle such suit without prior consent medinol avoidance doubt hereby expressly agreed that medinol shall have sole right obligation take action respect actual alleged threatened infringement medinol patent right style margin margin bottom text indent font size font family time roman ownership invention style margin margin bottom text indent font size font family time roman background subject right license expressly granted herein each party shall retain right title interest invention discovery other intellectual property right owned controlled party which such party otherwise right prior effective date style margin margin bottom text indent font size font family time roman sole invention style margin margin bottom text indent font size font family time roman subject right license expressly granted herein right title interest invention discovery other intellectual property right therein conceived invented solely personnel party without confidential information proprietary material other party connection with performance such party right obligation hereunder shall owned solely such party collectively sole style margin margin bottom text indent font size font family time roman medinol shall solely right title interest patent claim filed medinol after effective date which nbsp comprise invention conceived invented solely personnel medinol after effective date using style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman confidential information ariad permitted this agreement nbsp include limitation medical device nbsp comprise medical device method using medical device licensed field method treatment using medical device licensed field collectively medinol sole style margin margin bottom text indent font size font family time roman ariad shall solely right title interest patent claim filed ariad after effective date which nbsp comprise invention conceived invented solely personnel ariad after effective date using confidential information medinol permitted this agreement nbsp include limitation medical device nbsp comprise composition matter rapamycin analog rapamycin analog method treatment using rapamycin analog collectively ariad sole style margin margin bottom text indent font size font family time roman joint invention except otherwise forth this section nbsp right title interest invention discovery other intellectual property right therein conceived invented jointly personnel ariad medinol solely personnel party using confidential information proprietary material other party connection with performance such party right obligation hereunder shall jointly owned ariad medinol collectively joint except expressly provided this agreement understood that neither party shall have obligation account other profit obtain approval other party license exploit joint reason joint ownership thereof style margin margin bottom text indent font size font family time roman assignment party hereby agree execute deliver document including without limitation agreement relating assignment ownership right other party reasonably request give effect allocation ownership right forth this section style margin margin bottom text indent font size font family time roman license style margin margin bottom text indent font size font family time roman medinol hereby grant ariad exclusive royalty free fully paid sublicensable license under interest joint develop have developed make have made have used sell have sold offer sell import have imported export have exported distribute market promote product sale outside licensed field extent ariad retains right licensed field pursuant section nbsp also licensed field further event that medinol file patent application which discloses chemical structure analog descriptive information sufficient determine chemical structure analog claim medinol shall grant ariad exclusive royalty free fully paid style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman sublicensable license under interest claim whether such claim constitute medinol sole joint develop have developed make have made have used sell have sold offer sell import have imported export have exported distribute market promote product style margin margin bottom text indent font size font family time roman ariad hereby grant medinol exclusive royalty free fully paid sublicensable license under interest ariad sole joint develop have developed make have made have used sell have sold offer sell import have imported export have exported distribute market promote medinol license product sale licensed field style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign representation warranty table style margin margin bottom text indent font size font family time roman ariad representation ariad represents warrant medinol that style margin margin bottom text indent font size font family time roman execution delivery this agreement performance transaction contemplated hereby have been duly authorized appropriate ariad corporate action style margin margin bottom text indent font size font family time roman this agreement legal valid obligation binding upon ariad enforceable accordance with term execution delivery performance this agreement ariad conflict with agreement instrument understanding which ariad party which bound style margin margin bottom text indent font size font family time roman ariad owner sufficient right licensed patent right licensed technology grant medinol license granted under section nbsp licensed patent right full force effect free lien charge encumbrance security interest except those placed granted ordinary course business effective date best knowledge ariad there action claim threatened writing pending against ariad affiliate court with respect licensed patent right licensed technology style margin margin bottom text indent font size font family time roman effective date ariad intends develop make have made supply accordance with this agreement supply agreement style margin margin bottom text indent font size font family time roman medinol representation medinol represents warrant ariad that style margin margin bottom text indent font size font family time roman execution delivery this agreement performance transaction contemplated hereby have been duly authorized appropriate medinol corporate action style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman this agreement legal valid obligation binding upon medinol enforceable accordance with term execution delivery performance this agreement medinol conflict with agreement instrument understanding which medinol party which bound medinol further represents warrant that knowledge information that would affect validity licensed patent right style margin margin bottom text indent font size font family time roman effective date there action claim threatened writing pending against medinol affiliate court with respect medinol licensed product except forth schedule style margin margin bottom text indent font size font family time roman effective date medinol intends develop manufacture market sell medinol licensed product accordance with this agreement supply agreement style margin margin bottom text indent font size font family time roman warranty style margin margin bottom text indent font size font family time roman nothing this agreement shall construed nbsp warranty representation either party validity scope patent application patent licensed hereunder nbsp warranty representation that anything made used sold otherwise disposed under license granted pursuant this agreement will free from infringement patent copyright other right third party style margin margin bottom text indent font size font family time roman except expressly forth this agreement neither party make representation extends warranty kind either express implied with respect technology good service right other subject matter this agreement hereby disclaims express implied warranty merchantability fitness particular purpose infringement patent copyright trademark other right third party other express implied warranty style margin margin bottom text indent font size font family time roman event shall either party liable under result this agreement special indirect consequential incidental treble punitive exemplary style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman other similar type damage including limited loss profit business opportunity incurred other party whether contract tort based warranty even such party been advised possibility such damage style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign indemnification insurance table style margin margin bottom text indent font size font family time roman indemnification style margin margin bottom text indent font size font family time roman medinol indemnity medinol shall time during after term indemnify defend hold harmless ariad affiliate their respective director officer employee stockholder agent their respective successor heir assigns ariad indemnitees from against liability damage loss expense including reasonable attorney expense litigation incurred imposed upon such ariad indemnitees them connection with third party claim suit action demand judgment including without limitation personal injury product liability matter extent arising nbsp action omission medinol affiliate development testing production manufacture supply promotion import sale person medinol licensed product component thereof manufactured sold medinol affiliate under this agreement nbsp infringement intellectual property right third party through manufacture sale medinol licensed product except extent such infringement relates manufacture sale generally delivery medinol licensed product nbsp material breach this agreement medinol nbsp gross negligence willful misconduct part medinol director officer employee style margin margin bottom text indent font size font family time roman indemnification procedure event that indemnitee seeking indemnification under section nbsp above from party indemnifying party other party shall notify indemnifying party such claim with respect such indemnitee soon reasonably practicable after indemnitee receives notice claim party behalf itself such indemnitee shall permit indemnifying party assume direction control defense claim including right settle claim solely monetary consideration shall cooperate requested expense indemnifying style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman party defense claim provided however that indemnifying party shall agree settlement that adversely impact indemnitee without first seeking receiving indemnitee prior written consent indemnification obligation under article shall apply amount paid settlement claim demand action other proceeding such settlement effected without consent indemnifying party which consent shall withheld delayed unreasonably indemnitee employee agent shall reasonably cooperate with indemnifying party legal representative investigation claim demand action other proceeding covered section nbsp style margin margin bottom text indent font size font family time roman insurance style margin margin bottom text indent font size font family time roman ariad during term year thereafter ariad shall have maintain effect ariad sole cost following insurance relating ariad performance hereunder nbsp commercial general liability insurance each occurrence bodily injury property damage amount than dollar nbsp product liability insurance amount than dollar style margin margin bottom text indent font size font family time roman medinol during term year thereafter medinol shall have maintain effect medinol sole cost following insurance relating medinol performance hereunder nbsp commercial general liability insurance each occurrence bodily injury property damage amount than dollar nbsp product liability insurance amount than dollar style margin margin bottom text indent font size font family time roman scope insurance required this section nbsp shall cover performance under this agreement applicable party agent officer director employee representative style margin margin bottom text indent font size font family time roman additional insured ariad shall have medinol named additional insured under above insurance policy obtained ariad medinol shall have ariad named additional insured under above insurance policy obtained medinol such additional insured status shall procured evidenced additional insured endorsement policy certificate insurance style margin margin bottom text indent font size font family time roman certificate endorsement each party shall furnish valid certificate insurance endorsement other party evidencing that first party obtained insurance coverage required under this section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign term termination table style margin margin bottom text indent font size font family time roman term expiration term this agreement shall commence effective date unless earlier terminated accordance with this article shall expire upon later occur nbsp expiration final royalty payment obligation under section above nbsp fifteen nbsp year after first commercial sale medinol licensed product upon expiration term medinol shall have fully paid irrevocable license under licensed patent right licensed technology develop make have made import have imported export have exported sell have sold offer sell distribute market promote medinol licensed product within licensed field ariad shall provide medinol such confidential information ariad reasonably necessary that medinol possession expiration term medinol make have made medinol licensed product medinol acknowledges that such confidential information provided ariad pursuant this section nbsp ariad confidential information shall continue subject provision article following expiration term style margin margin bottom text indent font size font family time roman termination breach addition other remedy available equity this agreement terminated either party upon material breach other party obligation this agreement supply agreement such termination effective thirty nbsp case payment amount ninety nbsp case other curable material breach immediately case curable material breach after receipt breaching party written notice termination from breaching party describing such material breach this agreement supply agreement reasonable detail notwithstanding foregoing such default breach curable cured remedied shown existent within aforesaid case period cure period notice termination shall automatically withdrawn legal force effect provided that such cure period shall shortened appropriate such breach default must cured within extendible time limit forth governmental entity regulatory authority patent office termination based upon notice termination describing curable material breach shall stayed cure period tolled event that during cure period party alleged have materially breached this agreement shall have initiated dispute resolution accordance with section nbsp with respect alleged default which stay tolling shall last until final arbitral award made style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman termination bankruptcy event that either party file protection under bankruptcy make assignment benefit creditor appoints suffers appointment receiver trustee over property file petition under bankruptcy insolvency such petition filed against which discharged within sixty nbsp filing thereof then other party terminate this agreement effective immediately upon written notice such party style margin margin bottom text indent font size font family time roman termination without cause style margin margin bottom text indent font size font family time roman medinol terminate this agreement upon thirty prior written notice ariad nbsp medinol reasonably concludes that medinol licensed product will safe style margin margin bottom text indent font size font family time roman ariad terminate this agreement upon thirty prior written notice medinol pursuant section nbsp style margin margin bottom text indent font size font family time roman effect termination upon termination this agreement under section nbsp subject section nbsp effective date such termination style margin margin bottom text indent font size font family time roman termination reason material breach under section nbsp event termination this agreement material breach either party other than reason breach ariad described section nbsp termination this agreement medinol pursuant section nbsp above relevant license sublicenses granted ariad medinol hereunder ariad covenant medinol article party future obligation under article section through shall terminate automatically medinol shall liable make further payment ariad under this agreement other than payment accrued before date termination notwithstanding foregoing medinol affiliate shall have right sell otherwise dispose medinol licensed product then hand with royalty paid ariad sale such medinol licensed product provided this agreement style margin margin bottom text indent font size font family time roman termination reason ariad material breach supply agreement event termination this agreement breach ariad supply agreement termination this agreement ariad pursuant section nbsp above time following earlier initiation medinol pivotal clinical trial united state first commercial sale medinol medinol licensed product country nbsp relevant license sublicenses style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman granted ariad medinol hereunder shall remain full force effect nbsp party future obligation under article nbsp shall automatically terminate nbsp medinol shall have right nbsp without further consent required ariad access refer filing made ariad with regulatory authority solely furtherance medinol interest developing commercializing medinol licensed product nbsp disclose third party manufacturer with ariad providing introduction appropriate third party manufacturer medinol medinol request upon termination under this section nbsp under confidentiality agreement containing provision stringent that those forth article such information necessary establish alternate supply medinol licensed product nbsp medinol obligation pursuant section nbsp shall survive such termination nbsp medinol affiliate shall have right develop market sell medinol licensed product with royalty paid ariad sale such medinol licensed product provided this agreement style margin margin bottom text indent font size font family time roman remedy except otherwise expressly forth this agreement termination provision this section nbsp addition other relief remedy available either party equity provided however that event will medinol required amount beyond those payment medinol pursuant this agreement that accrued prior date termination style margin margin bottom text indent font size font family time roman surviving provision notwithstanding provision herein contrary right obligation party forth article except section nbsp section shall survive expiration termination term without limiting generality foregoing medinol shall have obligation make milestone payment ariad that accrued prior effective date termination this agreement shall remain liable such payment obligation accruing prior effective date such termination style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign dispute table style margin margin bottom text indent font size font family time roman party recognize that bona fide dispute certain matter from time time arise during term this agreement which relates either party right obligation hereunder event occurrence such dispute either party written notice other party have such dispute referred their respective senior official designated below their successor attempted resolution good faith negotiation within thirty nbsp after such notice received said designated senior official follows style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign nbsp medinol nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp valign bottom valign chief executive officer style font size height height colspan style font family time roman font size valign ariad valign bottom valign chief executive officer table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman event designated senior official able resolve such dispute within thirty nbsp period either party invoke provision section nbsp style margin margin bottom text indent font size font family time roman dispute controversy claim initiated either party arising resulting from relating this agreement performance either party obligation under this agreement other than bona fide third party action proceeding filed instituted action proceeding third party against party whether before after termination this agreement shall finally resolved binding arbitration whenever party shall decide institute arbitration proceeding shall give written notice that effect other party such arbitration shall conducted under commercial arbitration rule american arbitration association panel three arbitrator appointed accordance with such rule such arbitration shall held boston massachusetts method manner discovery such arbitration proceeding shall governed federal rule civil procedure local rule district court district massachusetts arbitrator shall have authority grant injunction specific performance allocate between party cost arbitration such equitable manner they determine judgment upon award rendered entered court having jurisdiction application made such court judicial acceptance award order enforcement case event shall demand arbitration made after date when institution legal equitable proceeding based upon such claim dispute other matter question would barred applicable statute limitation notwithstanding foregoing either party shall have right without waiving right remedy available such party under this agreement otherwise seek obtain from court competent jurisdiction interim provisional relief that necessary desirable protect right property such party pending selection arbitrator hereunder pending arbitrator determination dispute controversy claim hereunder style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign miscellaneous table style margin margin bottom text indent font size font family time roman notification notice request other communication hereunder shall writing shall addressed receiving party address forth below such other address party designate notice hereunder shall either nbsp delivered hand nbsp made facsimile transmission style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman followed with written confirmation nbsp sent private courier service providing evidence receipt nbsp sent registered certified mail return receipt requested postage prepaid address other contact information party follows style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign nbsp nbsp ariad valign bottom valign ariad pharmaceutical style font family time roman font size valign valign bottom valign ariad gene therapeutic style font family time roman font size valign valign bottom valign landsdowne street style font family time roman font size valign valign bottom valign cambridge style font family time roman font size valign valign bottom valign telephone style font family time roman font size valign valign bottom valign style font family time roman font size valign valign bottom valign attn chief legal officer style font size height height colspan style font family time roman font size valign with nbsp nbsp copy nbsp valign bottom valign mintz levin cohn ferris glovsky popeo style font family time roman font size valign valign bottom valign financial center style font family time roman font size valign valign bottom valign boston style font family time roman font size valign valign bottom valign phone style font family time roman font size valign valign bottom valign style font family time roman font size valign valign bottom valign attn jeffrey wiesen style font size height height colspan style font family time roman font size valign nbsp nbsp medinol nbsp nbsp valign bottom valign medinol style font family time roman font size valign valign bottom valign kiryat atidim style font family time roman font size valign valign bottom valign style font family time roman font size valign valign bottom valign aviv israel style font family time roman font size valign valign bottom valign style font family time roman font size valign valign bottom valign style font family time roman font size valign valign bottom valign attn kobi richter style font size height height colspan style font family time roman font size valign with copy valign bottom valign doron cohen david cohen office style font family time roman font size valign valign bottom valign abba hillel silver road style font family time roman font size valign valign bottom valign ramat israel style font family time roman font size valign valign bottom valign phone style font family time roman font size valign valign bottom valign style font family time roman font size valign valign bottom valign attn david cohen table style margin margin bottom font size font family time roman notice request other communication hereunder shall deemed have been given either nbsp hand time delivery thereof receiving party address such party forth above nbsp made telecopy facsimile transmission time that receipt thereof been acknowledged electronic confirmation otherwise unless business receiving which style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman event such communication shall deemed have been given next business nbsp sent private courier third nbsp business following such notice delivered courier service nbsp sent registered certified mail fifth nbsp business following such mailing made business sent internationally style margin margin bottom text indent font size font family time roman language this agreement been prepared english language english language shall control interpretation style margin margin bottom text indent font size font family time roman governing this agreement will construed interpreted applied accordance with commonwealth massachusetts excluding body controlling conflict style margin margin bottom text indent font size font family time roman limitation except forth elsewhere this agreement neither party grant other party right license intellectual property style margin margin bottom text indent font size font family time roman entire agreement this agreement supply agreement constitute entire agreement between party with respect subject matter hereof thereof supersede prior representation understanding agreement between party with respect subject matter hereof thereof modification this agreement shall effective unless writing with specific reference this agreement signed party event conflict between this agreement supply agreement term this agreement shall control style margin margin bottom text indent font size font family time roman waiver term condition this agreement waived only written instrument executed party waiving compliance failure either party time time require performance provision hereof shall manner affect right later time enforce same waiver either party condition term shall deemed continuing waiver such condition term another condition term style margin margin bottom text indent font size font family time roman heading section subsection heading inserted convenience reference only form part this agreement style margin margin bottom text indent font size font family time roman assignment neither this agreement right obligation hereunder assigned delegated otherwise transferred whole part either party without prior express written consent other provided however that nbsp each ariad pharmaceutical ariad gene therapeutic without written consent medinol assign this agreement affiliate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman connection with transfer sale substantially asset business related this agreement event merger consolidation change control similar transaction collectively change control nbsp medinol without ariad written consent assign this agreement affiliate transaction involving change control event change control ariad ariad shall commercially reasonable effort cause assignee agree that following effective date such change control such assignee shall take reasonable step segregate part business which developing manufacturing using selling medical device which directly competitive with medinol licensed product licensed field from those activity performed ariad after effective date such change control pursuant this agreement supply agreement event change control medinol medinol shall cause assignee agree that following effective date such change control assignment such assignee shall segregate part business which developing manufacturing using selling rapamycin rapamycin analog delivered stent which directly competitive with licensed patent right licensed field from those activity performed medinol after effective date such change control assignment pursuant this agreement supply agreement condition assignment permitted assignee under this section nbsp shall assume obligation assignor under this agreement separate written agreement signed assignor assignee purported assignment violation this section nbsp shall void term condition this agreement shall binding upon inure benefit permitted successor assigns party style margin margin bottom text indent font size font family time roman force majeure neither party shall liable failure delay performing obligation forth this agreement neither shall deemed breach obligation such failure delay natural disaster cause beyond reasonable control such party event such force majeure party affected thereby shall reasonable effort cure overcome same resume performance obligation hereunder style margin margin bottom text indent font size font family time roman construction party hereto acknowledge agree that nbsp each party counsel reviewed negotiated term provision this agreement have contributed revision nbsp rule construction effect that ambiguity resolved against drafting party shall employed interpretation this agreement nbsp term provision this agreement shall construed fairly party hereto favor against party regardless which party generally responsible preparation this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman severability provision this agreement become invalid ruled illegal court competent jurisdiction deemed unenforceable under then current applicable from time time effect during term hereof intention party that remainder this agreement shall affected thereby provided that party right under this agreement materially affected party hereto covenant agree renegotiate such term covenant application thereof good faith order provide reasonably acceptable alternative term covenant condition this agreement application thereof that invalid illegal unenforceable being intent party that basic purpose this agreement effectuated style margin margin bottom text indent font size font family time roman further assurance each party agrees execute acknowledge deliver such further instruction such other necessary appropriate order carry purpose intent this agreement style margin margin bottom text indent font size font family time roman independent contractor notwithstanding provision contrary herein relationship party that independent contractor nothing herein shall construed create partnership joint venture franchise employment agency relationship between party neither party shall have authority enter into agreement kind behalf other party shall either party have power authority bind obligate other party manner style margin margin bottom text indent font size font family time roman counterpart this agreement executed simultaneously more counterpart each which shall deemed original which together shall constitute same instrument style margin margin bottom font size font family time roman align center remainder page intentionally left blank style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman witness whereof party have caused this agreement executed their duly authorized representative three nbsp original style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size valign colspan medinol valign bottom valign valign bottom valign colspan ariad pharmaceutical style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman judith richter valign bottom valign valign bottom valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman laurie allen style font family time roman font size valign valign bottom valign valign bottom valign valign bottom valign name valign bottom valign laurie allen style font family time roman font size valign name valign bottom valign judith richter valign bottom valign valign bottom valign title valign bottom valign senior vice president chief legal officer style font family time roman font size valign title valign bottom valign chief executive officer valign bottom valign valign bottom colspan valign style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign valign bottom valign valign bottom valign colspan ariad gene therapeutic style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom valign valign bottom valign valign bottom valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman harvey berger style font family time roman font size valign valign bottom valign valign bottom valign valign bottom valign name valign bottom valign harvey berger style font family time roman font size valign valign bottom valign valign bottom valign valign bottom valign title valign bottom valign chairman chief executive officer table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center licensed patent right style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center supply agreement style margin margin bottom font size font family time roman align center attached following page style margin margin bottom font size nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman portion this exhibit were omitted have been filed separately with secretary commission pursuant company application requesting confidential treatment under rule security style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center country style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size nbsp body html text document